Supplemental material
Drug Delivery
Volume 25, 2018 - Issue 1
Research Article
Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy
, , , , 
, , & show all
Kristyn HuffmanDepartment of Ophthalmology, Jacobs Retina Center at Shiley Eye Institute, University of California, San Diego, CA, USA; http://orcid.org/0000-0002-3271-2518View further author information
http://orcid.org/0000-0002-3271-2518View further author information, , & show allRelated Research Data
Selection of Therapeutic Agents for Intraocular Proliferative Disease
Source:
American Medical Association (AMA)
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
Source:
Massachusetts Medical Society
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
Source:
Elsevier BV
Correlation between different gene expression assays designed to measure trans-activation potencies of systemic glucocorticoids
Source:
Elsevier BV
Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial
Source:
Elsevier BV
The Relation Between Bevacizumab Injection and the Formation of Subretinal Fibrosis in Diabetic Patients with Panretinal Photocoagulation
Source:
SLACK, Inc.
Low-Dose Anthracyclines May Block HIF-1 and Stop Tumor Growth
Source:
Oxford University Press (OUP)
Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection.
Source:
American Medical Association (AMA)
Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles
Source:
Elsevier BV
Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP).
Source:
Elsevier BV
Multifunctional mesoporous ZrO 2 encapsulated upconversion nanoparticles for mild NIR light activated synergistic cancer therapy
Source:
Elsevier BV
Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy
Source:
Taylor & Francis
Update on corticosteroids for diabetic macular edema
Source:
Dove Medical Press Ltd.
Effects of daunorubicin, mitomycin C, azathioprine and cyclosporin A on human retinal pigmented epithelial, corneal endothelial and conjunctival cell lines
Source:
Springer Nature
Prevention of experimental proliferative vitreoretinopathy with daunomycin and triamcinolone based on the time course of the disease
Source:
Springer Nature
A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics
Source:
Association for Research in Vision and Ophthalmology (ARVO)
Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy
Source:
Taylor & Francis
Development of Subretinal Fibrosis After Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration
Source:
SLACK, Inc.
Control of experimental massive periretinal proliferation by daunomycin: dose-response relation
Source:
Springer Nature
Dual Drug Release of Triamterene and Aminophylline from Poly (N-Isopropylacrylamide) Hydrogels
Source:
SAGE Publications
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
EXACERBATION OF CHOROIDAL AND RETINAL PIGMENT EPITHELIAL ATROPHY AFTER ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Source:
Ovid Technologies (Wolters Kluwer Health)
Porous silicon for drug delivery applications and theranostics: recent advances, critical review and perspectives
Source:
Informa UK Limited
Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide
Source:
Association for Research in Vision and Ophthalmology (ARVO)
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon
Source:
Elsevier BV
Slow-Release Dexamethasone in Proliferative Vitreoretinopathy: A Prospective, Randomized Controlled Clinical Trial.
Source:
Elsevier BV
Highly Emissive Dye-Sensitized Upconversion Nanostructure for Dual-Photosensitizer Photodynamic Therapy and Bioimaging
Source:
American Chemical Society (ACS)
Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment
Source:
Future Medicine Ltd
Anthracyclines, Small-Molecule Inhibitors of Hypoxia-Inducible Factor-1 Alpha Activation
Source:
Pharmaceutical Society of Japan
Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema.
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Inflammation and age-related macular degeneration (AMD).
Source:
Informa UK Limited
Recruitment of Blood-Derived Inflammatory Cells Mediated via Tumor Necrosis Factor-α Receptor 1b Exacerbates Choroidal Neovascularization
Source:
Association for Research in Vision and Ophthalmology (ARVO)
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Source:
Elsevier BV
Yolk-Structured Upconversion Nanoparticles with Biodegradable Silica Shell for FRET Sensing of Drug Release and Imaging-Guided Chemotherapy
Source:
American Chemical Society (ACS)
Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics
Source:
Informa UK Limited
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy
Source:
Taylor & Francis
Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide
Source:
Elsevier BV
INTRAOCULAR PRESSURE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE INTRAVITREAL IMPLANT IN THE 3-YEAR MEAD STUDY
Source:
Ovid Technologies (Wolters Kluwer Health)
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit
Source:
Springer Nature
The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment
Source:
Springer Nature
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Characterization of Daunorubicin-Induced Apoptosis in Retinal Pigment Epithelial Cells: Modulation by CD95L
Source:
Association for Research in Vision and Ophthalmology (ARVO)
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Porous silicon in drug delivery devices and materials
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Diabetic Retinopathy: More Than Meets the Eye
Source:
Elsevier BV
Linking provided by
